134 related articles for article (PubMed ID: 34843654)
21. Intraprocedure contrast enhanced ultrasound: the value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids.
Peng S; Hu L; Chen W; Chen J; Yang C; Wang X; Zhang R; Wang Z; Zhang L
Ultrasonics; 2015 Apr; 58():123-8. PubMed ID: 25627929
[TBL] [Abstract][Full Text] [Related]
22. Magnetic Resonance Imaging Parameters in Predicting the Treatment Outcome of High-intensity Focused Ultrasound Ablation of Uterine Fibroids With an Immediate Nonperfused Volume Ratio of at Least 90.
Keserci B; Duc NM
Acad Radiol; 2018 Oct; 25(10):1257-1269. PubMed ID: 29525424
[TBL] [Abstract][Full Text] [Related]
23. Efficacy, Efficiency, and Safety of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Ablation of Uterine Fibroids: Comparison with Ultrasound-Guided Method.
Wang Y; Wang ZB; Xu YH
Korean J Radiol; 2018; 19(4):724-732. PubMed ID: 29962878
[TBL] [Abstract][Full Text] [Related]
24. [Feasibility and safety of MRgFUS ablation for uterine fibroids and adenomyosis: a preliminary study].
Huang YQ; Zhou SG; Wang J; Deng LX; Li ZW; Xu YH
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1152-1155. PubMed ID: 31006218
[No Abstract] [Full Text] [Related]
25. [Prospective study on magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroid: short-term follow up].
Fan R; Zhu L; Gong XM; Xue HD; Shi HF; Jin ZY; Chen GJ
Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):183-7. PubMed ID: 23849940
[TBL] [Abstract][Full Text] [Related]
26. Technical eligibility for treatment of magnetic resonance-guided focused ultrasound surgery.
Fröling V; Kröncke TJ; Schreiter NF; Scheurig-Muenkler C; Collettini F; Hamm B; Beck A
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):445-50. PubMed ID: 23839005
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with thermal injury of abdominal skin in focused ultrasound ablation of uterine fibroids.
Chendian T; Guohua H; Wang Z; Fang L; Luo S; Liu X; Shi Q
Int J Hyperthermia; 2024; 41(1):2295232. PubMed ID: 38159557
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging parameters in predicting the ablative efficiency of high-intensity focused ultrasound for uterine fibroids.
Gong C; Lin Z; Lv F; Zhang L; Wang Z
Int J Hyperthermia; 2021; 38(1):523-531. PubMed ID: 33781153
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging.
Zhao WP; Chen JY; Zhang L; Li Q; Qin J; Peng S; Li KQ; Wang ZB; Chen WZ
Eur J Radiol; 2013 Jan; 82(1):e43-9. PubMed ID: 23000188
[TBL] [Abstract][Full Text] [Related]
30. The value of acoustic radiation force impulse imaging in preoperative prediction for efficacy of high-Intensity focused ultrasound uterine fibroids ablation.
Zhang DL; Liu XX; Tang JQ; Wu SS; Lin N; Ding GS; Pan XL; Chen S
Int J Hyperthermia; 2020; 37(1):423-429. PubMed ID: 32354241
[No Abstract] [Full Text] [Related]
31. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas.
Taran FA; Tempany CM; Regan L; Inbar Y; Revel A; Stewart EA;
Ultrasound Obstet Gynecol; 2009 Nov; 34(5):572-8. PubMed ID: 19852046
[TBL] [Abstract][Full Text] [Related]
32. Volumetric magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids through abdominal scars: the impact of a scar patch on therapeutic efficacy and adverse effects.
Keserci B; Duc NM
J Ther Ultrasound; 2017; 5():22. PubMed ID: 28824811
[TBL] [Abstract][Full Text] [Related]
33. The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main Polish center and a review of current data.
Łoziński T; Filipowska J; Gurynowicz G; Zgliczyńska M; Kluz T; Jędra R; Skowyra A; Ciebiera M
Int J Hyperthermia; 2019; 36(1):582-590. PubMed ID: 31159642
[No Abstract] [Full Text] [Related]
34. Mid-term clinical efficacy of a volumetric magnetic resonance-guided high-intensity focused ultrasound technique for treatment of symptomatic uterine fibroids.
Ikink ME; Voogt MJ; Verkooijen HM; Lohle PN; Schweitzer KJ; Franx A; Mali WP; Bartels LW; van den Bosch MA
Eur Radiol; 2013 Nov; 23(11):3054-61. PubMed ID: 23793518
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging-guided focused ultrasound surgery for symptomatic uterine fibroids: estimation of treatment efficacy using thermal dose calculations.
Yoon SW; Cha SH; Ji YG; Kim HC; Lee MH; Cho JH
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):304-8. PubMed ID: 23523412
[TBL] [Abstract][Full Text] [Related]
36. Volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids: treatment speed and factors influencing speed.
Park MJ; Kim YS; Keserci B; Rhim H; Lim HK
Eur Radiol; 2013 Apr; 23(4):943-50. PubMed ID: 23080072
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus.
Zhang L; Chen WZ; Liu YJ; Hu X; Zhou K; Chen L; Peng S; Zhu H; Zou HL; Bai J; Wang ZB
Eur J Radiol; 2010 Feb; 73(2):396-403. PubMed ID: 19108974
[TBL] [Abstract][Full Text] [Related]
38. The role of T1 perfusion-based classification in magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids.
Keserci B; Duc NM
Eur Radiol; 2017 Dec; 27(12):5299-5308. PubMed ID: 28616725
[TBL] [Abstract][Full Text] [Related]
39. [Clinical outcome of magnetic-resonance-guided focused ultrasound surgery (MRgFUS) in the treatment of symptomatic uterine fibroids].
Kamp JE; David M; Scheurig-Muenkler C; Hengst S; Beck A
Rofo; 2013 Feb; 185(2):136-43. PubMed ID: 23196835
[TBL] [Abstract][Full Text] [Related]
40. Adverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids - a systematic review and future perspectives.
Kociuba J; Łoziński T; Zgliczyńska M; Byrczak M; Vitale SG; Skrzypczak M; Zaręba K; Ciebiera M
Int J Hyperthermia; 2023; 40(1):2174274. PubMed ID: 36775655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
